Table 2.
Demographics and disease characteristics of patients
| Characteristic | Patients with ONDs | Patients with MS |
|---|---|---|
| Total, n | 35 | 45 |
| ELISA | 23 | 39 |
| ELISPOT | 35 | 45 |
| Female sex, % | 60 | 67.5 |
| Age, median (range), y | 56 (24–88) | 48 (20–70) |
| Time since diagnosis, median (range), y | NA | 11 (0.75–33) |
| EDSS score (range) | NA | 2.5 (1–5.5) |
| Consumption of milk,∗ median (range), mL/d | 42.85 (0–400) | 53.35 (0–1,000) |
| Consumption of cream,∗ median (range), g/d | 0 (0–35) | 0 (0–28) |
| Consumption of cheese,∗ median (range), g/d | 14.28 (0–100) | 14.28 (0–71) |
| ELISPOT casein responders, %† | 28 | 42 |
| ELISA OD value > 1.0, %† | 21.7 | 41.02 |
EDSS, expanded disability status scale; NA, not applicable.
∗Data for 35 patients with ONDs and 39 patients with MS.
†The table indicates values for the ELISA and ELISPOT assays that were both directed against bovine casein.